🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present clinical study will assess the immunogenicity and reactogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00319852
Treatments Being Tested
The study will evaluate the immunogenicity of the Diphtheria, Tetanus, Pert...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-19
Trial ID
NCT01926015
Treatments Being Tested
This study is designed to study the immunogenicity and safety of sIPV co-ad...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Start Date
2023-05-22
Trial ID
NCT05850364
Treatments Being Tested
Subjects aged 9 to 13 years who participated in the 711866/001 study 5 year...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-01
Trial ID
NCT00635128
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-09-16
Trial ID
NCT02907216
Treatments Being Tested
If your serious vaccine-induced adverse event has been entered in the CDC V...
Status
Unknown
Location
Neuroganics LLC
Start Date
2022-03-15
Trial ID
NCT05095844
Treatments Being Tested
The main purpose of this study is to evaluate immune persistence at 30 and ...
Status
Recruiting
Location
Jingsu Provincial Centre of Disease Control and Prevention
Start Date
2024-09-05
Trial ID
NCT06605755
Treatments Being Tested
This study has three purposes: To investigate whether the immune response ...
Status
Unknown
Location
Radbdoudumc
Start Date
2015-01
Trial ID
NCT02771782
Treatments Being Tested
This is a single-center, randomized, active-controlled, parallel-group, ope...
Status
Completed
Location
Korea University Guro Hospital
Start Date
2017-07-03
Trial ID
NCT03208101
Treatments Being Tested
The purpose of this Phase II study is to evaluate the feasibility of GSK Bi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-06-24
Trial ID
NCT00871338
Treatments Being Tested